文献速递肿瘤 PET/CT放射性药物与辐射防护

靶向极迟抗原-4的正电子发射断层显像可视化γδ T细胞

Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2022-07-06

本研究在荷瘤小鼠过继转移γδ T细胞后,用靶向VLA-4的示踪剂68Ga-LLP2A进行纵向PET/CT显像,发现肿瘤对示踪剂摄取随时间增加,组织学证实肿瘤内存在表达VLA-4的γδ T细胞,作者称这是首个用于活体肿瘤内γδ T细胞成像的分子探针。

要点

  • 68Ga-LLP2A在体外及过继转移γδ T细胞的荷瘤小鼠中对表达VLA-4的γδ T细胞显示高特异性。
  • 纵向PET显像显示过继转移γδ T细胞后肿瘤示踪剂摄取增加,揭示γδ T细胞向肿瘤特异性归巢。
  • 组织学分析证实肿瘤内存在表达VLA-4的γδ T细胞。

核心结论

  • 作者称据其所知首次报道了用于活体肿瘤内γδ T细胞成像的分子探针68Ga-LLP2A,推进了γδ T细胞的PET成像,并支持将显像剂转化用于免疫治疗监测。

研究设计与样本

  • 在MDA-MB-231和A549荷瘤小鼠过继转移γδ T细胞后,用靶向VLA-4的示踪剂68Ga-LLP2A进行纵向PET/CT显像,并以离体生物分布研究和免疫组化验证。

主要发现

  • 68Ga-LLP2A在体外及过继转移γδ T细胞的荷瘤小鼠中对表达VLA-4的γδ T细胞显示高特异性。
  • 荷瘤小鼠过继转移γδ T细胞后,68Ga-LLP2A纵向PET显像显示肿瘤示踪剂摄取增加,揭示γδ T细胞向肿瘤特异性归巢。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: γδ T cell-based immunotherapy has been rolled out as a promising treatment strategy for malignant tumors due to their potent anti-tumor cytotoxicity, ease of expansion, and unrestricted MHC feature. However, the dynamics and outcomes of γδ T cells in tumor sites are poorly understood. Reported strategies rely on ex vivo biolabeling, significantly limiting the application of γδ T cell molecular imaging. Herein, we investigated whether VLA-4 (very late antigen-4), a crucial component in the effective trafficking of lymphocytes, could serve as a biomarker to non-invasively visualize γδ T cells. METHODS: VLA-4-targeted tracer, 68 Ga-LLP2A, was evaluated in MDA-MB-231- and A549-bearing mice with adoptive transfer of γδ T cells by longitudinal PET/CT imaging. Imaging data were verified by ex vivo biodistribution studies, and the co-localization of CD3 and VLA-4 was validated by immunohistochemistry studies. RESULTS: 68 Ga-LLP2A showed high specificity to VLA-4-expressing γδ T cells in both in vitro and tumor-bearing mice with adoptive transfer of γδ T cells. Longitudinal PET imaging of 68 Ga-LLP2A in tumor-bearing mice with adoptive transfer of γδ T cells showed an increasing tumor tracer uptake, revealing the tumor-specific homing of γδ T cells. The presence of VLA-4-expressing γδ T cells in tumors was confirmed via histological analysis. CONCLUSION: To the best of our knowledge, we reported the first molecular probe, 68 Ga-LLP2A, for in vivo imaging of γδ T cells in live tumors, which advances PET imaging of γδ T cells and supports the translation of imaging agents for immunotherapeutic monitoring.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Long Y, Lv X, Song X, et al. Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography. Eur J Nucl Med Mol Imaging. 2022. PMID: 35790537. doi:10.1007/s00259-022-05886-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。